3 Jun 2013

Omixon and Knome partner to offer advanced HLA typing for whole genome and exome level data

CAMBRIDGE, MA — June 3, 2013 – Knome Inc., the human genome interpretation company, today announced that its Services division will now provide its clients with advanced HLA typing capabilities as part of its whole genome and exome interpretation offerings. … more

6 May 2013

Knome and Real Time Genomics Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS™100 System

Partnership to bring accurate and fast genome analysis to translational researchers CAMBRIDGE, MA –  May 6, 2013 – Knome Inc., the genome interpretation company, and Real Time Genomics, Inc., the genome analytics company, today announced that the Real Time Genomics (RTG) Variant platform … more

27 Sep 2012

Knome Introduces the knoSYS™100

First Plug-and-Play Human Genome Interpretation System – Big data technology breaks the genome interpretation bottleneck – An in silico genetic testing “lab in a box” – More than a dozen leading institutions join early access program   CAMBRIDGE, MA –  September … more

Dr. Rehm brings deep experience in clinical genomics and patient care as Knome continues to expand CAMBRIDGE, MA – July 9, 2012 –  Knome Inc., the human genome interpretation company, announced today that a leading clinical geneticist, … more

12 Jun 2012

Knome Appoints Gary A. Cohen as Senior Vice President and General Counsel

CAMBRIDGE, MA – June 11, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has appointed Gary A. Cohen, JD, MPH, as Senior Vice President, General Counsel and Secretary of the company.  In … more

3 Apr 2012

Knome selected as a genome interpretation partner for Illumina Genome Network

Firms partner to offer Illumina’s high-quality genome sequencing services in combination with Knome’s advanced genome interpretation solutions CAMBRIDGE, MA – April 3, 2012 – Knome Inc., the human genome interpretation company, announced today that it has been … more

3 Apr 2012

Knome appoints Hugh Y. Rienhoff, Jr., MD to Scientific Advisory Board

Dr. Rienhoff brings deep industry and technical expertise as Knome continues to expand CAMBRIDGE, MA – April 3, 2012 – Knome, Inc., the human genome interpretation company, today announced that it has continued to expand its scientific … more

9 Jan 2012

Knome Selected as Technology Partner by Johns Hopkins for Landmark 1,000 Genomes Asthma Research

Knome’s informatics and software tools to be used to interpret whole genomes of African American and African Caribbean asthma patients   CAMBRIDGE, MA – January 9, 2012 – Knome, Inc., the human genome interpretation company, today announced … more